Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Teng Long,1,2,* Zhoutian Yang,1,2,* Huilan Zeng,1,2,* Weijie Wu,1,2 Zhiwen Hu,1,2 Zhenyun Yang,1,2 Dandan Hu,1,2 Zhongguo Zhou,1,2 Minshan Chen,1,2 Yaojun Zhang1,2 1State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Long T, Yang Z, Zeng H, Wu W, Hu Z, Hu D, Zhou Z, Chen M, Zhang Y
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2023-10-01
Edice:	Journal of Hepatocellular Carcinoma
Témata:	transarterial chemoembolization hepatic arterial infusion chemotherapy tyrosine kinase inhibitors programmed cell death protein -1 combination therapy hepatocellular carcinoma
On-line přístup:	https://www.dovepress.com/comparable-clinical-outcomes-between-transarterial-chemoembolization-o-peer-reviewed-fulltext-article-JHC
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!